An advisory panel of the U.S. Centers for Disease Control and Prevention will meet on Nov. 2 to discuss the use of Covid-19 vaccines in children...
Spain’s on-demand delivery platform Glovo has announced what it’s calling “The Couriers Pledge” — an initiative which commits its business to setting a new — “fairer”...
Another weapon against Covid-19 could be made more prominent as results from a large, placebo-controlled trial published in the Lancet on Wednesday evening provide compelling evidence...
Can these penny stocks show potential at current prices? The post Are These Penny Stocks Bargains at Current Levels? appeared first on Penny Stocks to Buy,...
How Long Until Supply Chains Finally Normalize: Three Things To Watch Earlier today, Morgan Stanley showed that more than inflation, more than concerns about the historic...
Sunak talked about a new age of optimism, but it doesn’t feel like that for many people.
Teva Pharmaceutical Industries Ltd. inked a deal to license and develop two of MODAG GmbH’s compounds in neurodegenerative disease.
Malvern, Pa.-based Ocugen submitted an Investigational New Drug Application to the U.S. Food and Drug Administration to run a Phase III trial of India’s Covid-19 vaccine BBV152...
Gringo, a Brazilian startup that has built an app aimed at supporting drivers in a variety of ways, has raised $8 million in a new round...
Are these consumer staples a must-have in your portfolio now? The post Best Stocks To Buy Today? 4 Consumer Staples Stocks For Your List appeared first...
Loonie Soars After Bank of Canada Ends QE Early, Accelerates Rate Hike Timing To Mid-2022 Another day, another hawkish surprise from a developed central bank. While...
30Y Gilts Soar Most Since Covid Crisis In Giant Short Squeeze After UK Slashes Debt Issuance While it is of secondary importance to US readers, in...
GM Shares Slump Despite Company Raising Full Year Guidance Semiconductor shortage or not, General Motors posted a Q3 report that handily beat the street's estimates. The...
A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in...
GlaxoSmithKline said today it would halt further development of its antibody for severe COVID-19 pneumonia – otilimab – The post GSK side-lines COVID drug otilimab to...
Merck & Co has signed a licensing deal with the UN-backed Medicines Patent Pool (MPP) that could pave The post Merck takes further steps to expand...
We may not be attracted to movie violence as much as people think.
- by New Deal democratWell, we got some definite good news yesterday in the FDA approval of vaccines for children ages 5-11. Probably about 1/2 of...
The euro is treading in calm waters on Wednesday, ahead of the ECB policy meeting tomorrow. Currently, EUR/USD is trading at 1.1595, down 0.01% on the...
By Kristalina Georgieva G20 should lead in sharing vaccine doses, helping developing countries financially, and committing to reaching net-zero carbon emissions by mid-century. When G20 leaders...
Naturally Splendid Enterprises Ltd. (“Naturally Splendid“, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that a selection of NATERA Plant-Based Foods were featured...
Listen to the fourth episode of a new series from The Anthill Podcast ahead of the COP26 climate change summit in Glasgow.
From the indie to the blockbuster, Halloween viewing recommendations whatever your taste.
This is a transcript of part 4 of Climate Fight: the world’s biggest negotiation, a series from The Anthill podcast.
South African online healthcare marketplace RecoMed has raised a $1.5 million financing round, the company confirmed to TechCrunch. The round was led by South Africa-focused venture...
Its proprietary fermentation process will enable QOA to scale production by 2035 and be able to price its "chocolate" products the same or below the cost...
Cases are high in people over 60, who are far more likely to develop severe COVID and need hospital treatment.
The small executive team at Cardurion has been sticking carefully to its goals, in-licensing a lead cardio drug from Astellas in 2018 and making a careful...
What is the Federal Reserve Hiding From Us? "The most inappropriate monetary policy that I've seen maybe in my lifetime."- Paul Tudor Jones on the Federal...
Re-Imposing COVID Restrictions Would Cost UK Up To £18 Billion Authored by Paul Joseph Watson via Summit News, Boris Johnson has been warned that any move...